MNKD - Financial Reports List - MannKind Corporation - IntrinsicAlpha

MannKind Corporation MNKD

Healthcare - Biotechnology - NASDAQ - US

$ 4.58

-2.2 %

$ 1.39 B

Market Cap

44.4

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	31.30%	429.76%	149.15%
Annual Report	FY	10-K	2024-12-31	43.50%	331.09%	736.45%
Quarterly Report	Q3	8-K	2024-09-30	36.73%	571.12%	150.34%
Quarterly Report	Q2	8-K	2024-06-30	48.91%	61.75%	834.40%
Quarterly Report	Q1	8-K	2024-03-31	63.10%	166.37%	403.79%
Quarterly Report	Q4	8-K	2023-12-31	62.16%	106.03%	214.15%
Annual Report	FY	10-K	2023-12-31	99.42%	89.36%	112.59%
Quarterly Report	Q3	8-K	2023-09-30	56.14%	108.73%	144.68%
Quarterly Report	Q2	8-K	2023-06-30	157.28%	81.86%	108.41%
Quarterly Report	Q1	8-K	2023-03-31	238.78%	48.53%	78.30%

1